Skip to main content
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. — Investor Relations & Filings

Ticker · APUS US Manufacturing
Filings indexed 109 across all filing types
Latest filing 2025-12-10 Regulatory Filings
Country US United States of America
Listing US APUS

About Apimeds Pharmaceuticals US, Inc.

https://www.apimedsus.com/

Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing its lead product candidate, Apitox. This non-opioid, biologic drug is derived from bee venom and is intended for intradermal administration to treat pain associated with osteoarthritis of the knee. Following a merger with MindWave, the company has integrated its biotechnology development with a focus on AI-driven digital treasury and yield generation solutions.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 1 TO FORM 8-K
Regulatory Filings
2025-12-10 English
CURRENT REPORT
Regulatory Filings
2025-12-02 English
425 Filing
Regulatory Filings
2025-12-02 English
PRIMARY DOCUMENT
Director's Dealing
2025-11-22 English
CURRENT REPORT
Regulatory Filings
2025-11-18 English
PRIMARY DOCUMENT
Director's Dealing
2025-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.